Skip to main content

Pyxis Oncology, Inc.

PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001782223

In the last 90 days, Pyxis Oncology, Inc. insiders filed 0 open-market purchases and 1 sale; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Pyxis Oncology, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
−6 vs. Q4 2021
Shares held
18.9M
+607.7K (+3.3%) vs. Q4 2021
Total value
$76.1M
−$123.8M (−61.9%) vs. Q4 2021
New holders
5
14 more added
Sold out
11
14 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PYXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 45 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 51 institutionsQ1 2022: 45 institutionsQ2 2022: 39 institutionsQ3 2022: 38 institutionsQ4 2022: 31 institutionsQ1 2023: 47 institutionsQ2 2023: 48 institutionsQ3 2023: 54 institutionsQ4 2023: 51 institutionsQ1 2024: 71 institutionsQ2 2024: 80 institutionsQ3 2024: 92 institutionsQ4 2024: 99 institutionsQ1 2025: 89 institutionsQ2 2025: 74 institutionsQ3 2025: 73 institutionsQ4 2025: 79 institutionsQ1 2026: 78 institutionsQ2 2026: 76 institutions
Value heldQ1 2022: $76.1M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $199.9MQ1 2022: $76.1MQ2 2022: $47.7MQ3 2022: $38.3MQ4 2022: $26.5MQ1 2023: $41.5MQ2 2023: $24.6MQ3 2023: $15.4MQ4 2023: $15.8MQ1 2024: $97.7MQ2 2024: $93.1MQ3 2024: $102.3MQ4 2024: $49.2MQ1 2025: $29.6MQ2 2025: $30.2MQ3 2025: $59.7MQ4 2025: $34.7MQ1 2026: $40.5MQ2 2026: $101.1M
Institutions holding PYXS and their total value by quarter
QuarterHoldersValue
Q2 202676$101.1M
Q1 202678$40.5M
Q4 202579$34.7M
Q3 202573$59.7M
Q2 202574$30.2M
Q1 202589$29.6M
Q4 202499$49.2M
Q3 202492$102.3M
Q2 202480$93.1M
Q1 202471$97.7M
Q4 202351$15.8M
Q3 202354$15.4M
Q2 202348$24.6M
Q1 202347$41.5M
Q4 202231$26.5M
Q3 202238$38.3M
Q2 202239$47.7M
Q1 202245$76.1M
Q4 202151$199.9M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Pyxis Oncology, Inc.; share changes are against Q4 2021.

Institutions holding PYXS in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc2,861,851$11.6M0.46%+1,070,500+59.8%Added
Ra Capital Management, L.P.2,282,173$9.22M0.20%00.0%Unchanged
RTW Investments, LP2,120,760$8.57M0.18%00.0%Unchanged
Perceptive Advisors LLC1,528,812$6.18M0.13%−415,302−21.4%Reduced
Citadel Advisors LLC1,522,498$6.06M0.01%+881+0.1%Added
Janus Henderson Group PLC1,396,967$5.49M0.00%−72,124−4.9%Reduced
Laurion Capital Management LP1,219,832$4.93M0.12%+57,500+4.9%Added
Barclays PLC949,387$3.83M0.00%+949,387New
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)764,406$3.09M0.06%00.0%Unchanged
Cormorant Asset Management, LP668,854$2.70M0.21%00.0%Unchanged
Tekla Capital Management LLC708,303$2.63M0.09%+573,303+424.7%Added
Vanguard Group Inc526,309$2.13M0.00%+6,011+1.2%Added
BlackRock Inc.520,901$2.10M0.00%+7,053+1.4%Added
Logos Global Management LP286,652$1.16M0.15%00.0%Unchanged
Citigroup Inc233,129$942.0K0.00%+229,923+7,171.6%Added
HealthCor Management, L.P.217,457$879.0K0.06%−27,381−11.2%Reduced
Acuta Capital Partners, LLC200,000$808.0K0.38%−477,753−70.5%Reduced
Geode Capital Management, LLC194,577$786.0K0.00%+13,105+7.2%Added
State Street Corp144,795$585.0K0.00%+51,920+55.9%Added
OrbiMed Advisors LLC143,640$580.0K0.01%00.0%Unchanged
Pura Vida Investments, LLC113,362$458.0K0.06%+600+0.5%Added
Northern Trust Corp88,329$357.0K0.00%−906−1.0%Reduced
Ghost Tree Capital, LLC75,000$303.0K0.15%−220,000−74.6%Reduced
Bank of New York Mellon Corp32,589$132.0K0.00%+13,305+69.0%Added
Deutsche Bank AG30,783$124.0K0.00%−678−2.2%Reduced
Charles Schwab Investment Management Inc23,094$94.0K0.00%00.0%Unchanged
Bank of America Corp20,278$82.0K0.00%−8,338−29.1%Reduced
Nuveen Asset Management, LLC16,163$65.0K0.00%00.0%Unchanged
Tudor Investment Corp Et Al13,624$55.0K0.00%00.0%Unchanged
New York State Common Retirement Fund6,385$26.0K0.00%+108+1.7%Added
Wells Fargo & Company5,315$21.0K0.00%−6,099−53.4%Reduced
American International Group, Inc.5,278$21.0K0.00%−372−6.6%Reduced
JPMorgan Chase & Co4,986$20.0K0.00%−6,783−57.6%Reduced
California State Teachers Retirement System4,311$17.0K0.00%−1,545−26.4%Reduced
Morgan Stanley3,186$12.0K0.00%+354+12.5%Added
Tower Research Capital LLC (TRC)2,623$11.0K0.00%+1,960+295.6%Added
STRS Ohio2,500$10.0K0.00%00.0%Unchanged
UBS Group AG1,432$6.00K0.00%−3,386−70.3%Reduced
Amalgamated Bank1,543$6.00K0.00%+1,543New
Amalgamated Financial Corp.1,543$6.00K0.00%+1,543New
Legal & General Group Plc975$4.00K0.00%00.0%Unchanged
Royal Bank of Canada653$3.00K0.00%−1,483−69.4%Reduced
Ameritas Investment Partners, Inc.822$3.00K0.00%00.0%Unchanged
FMR LLC129$1.00K0.00%+129New
Massmutual Trust Co FSB133$1.00K0.00%+133New
Great Point Partners LLC0$00.00%−400,000−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−311,754−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−249,762−100.0%Sold out
Caas Capital Management LP0$00.00%−50,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−31,328−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−30,000−100.0%Sold out
Walleye Capital LLC0$00.00%−15,933−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−10,367−100.0%Sold out
Millennium Management LLC0$00.00%−10,253−100.0%Sold out
Sandia Investment Management LP0$00.00%−10,000−100.0%Sold out
Davidson Kempner Capital Management LP0$00.00%−10,000−100.0%Sold out